C
West Pharmaceutical Services, Inc. WST
$231.46 $1.350.59%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -4.34% 22.19% -3.47% -15.84% -15.07%
Total Depreciation and Amortization 1.24% 3.34% 9.27% -0.84% 0.56%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -205.00% 471.43% -63.16% -95.17% 373.49%
Change in Net Operating Assets 23,600.00% -100.71% 140.75% -228.62% 8.47%
Cash from Operations 5.55% 9.15% 39.59% -50.56% 3.91%
Capital Expenditure -29.03% 18.86% -10.60% 16.65% -13.47%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 112.50% 20.00% -- -- -200.00%
Cash from Investing -27.65% 18.87% -11.70% 16.73% -13.69%
Total Debt Issued -100.00% 270.57% -- -- --
Total Debt Repaid 99.92% -128.08% -9,633.33% 14.29% -16.67%
Issuance of Common Stock -48.33% -11.76% -59.52% 441.94% -84.80%
Repurchase of Common Stock -4.20% 72.01% 31.28% -53.81% -530.25%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -5.52% 0.68% 0.68% 0.68% -5.71%
Other Financing Activities -- -- 200.00% -- --
Cash from Financing -6.99% 70.50% 19.45% -43.01% -749.78%
Foreign Exchange rate Adjustments -304.50% 1,109.09% 87.36% -160.00% 247.96%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -114.09% 128.73% 38.28% -463.98% -143.70%
Weiss Ratings